|
1
|
Bochner BS, Undem BJ and Lichtenstein LM:
Immunological aspects of allergic asthma. Annu Rev Immunol.
12:2951994. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fabbri LM, Romagnoli M, Corbetta L, et al:
Differences in airway inflammation in patients with fixed airflow
obstruction due to asthma or chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 167:418–424. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Robinson DS, Hamid Q, Ying S, Tsicopoulos
A, Barkans J, et al: Predominant TH2-like bronchoalveolar
T-lymphocyte population in atopic asthma. N Engl J Med.
326:2981992. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shalaby KH and Martin JG: Overview of
asthma: the place of the T cell. Curr Opin Pharmacol. 10:218–225.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
DeGrendele HC, Estess P and Siegelman MH:
Requirement for CD44 in activated T cell extravasation into an
inflammatory site. Science. 278:672–675. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Katoh S, Ishii N, Nobumoto A, et al:
Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a
murine model of allergic asthma. Am J Respir Crit Care Med.
176:27–35. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Katoh S, Kaminuma O, Hiroi T, et al: CD44
is critical for airway accumulation of antigen-specific Th2, but
not Th1, cells induced by antigen challenge in mice. Eur J Immunol.
41:3198–3207. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Goodfellow PN, Banting G, Wiles MV, et al:
The gene, MIC4, which controls expression of the antigen defined
bymonoclonal antibody F10.44.2 is on human chromosome 11. Eur J
Immunol. 12:659–663. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ponta H, Sherman L and Herrlich PA: CD44:
from adhesion molecules to signalling regulators. Nat Rev Mol Cell
Biol. 4:33–45. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Denhardt DT, Noda M, O’Regan AW, et al:
Osteopontin as a means to cope with environmental insults:
regulation of inflammation, tissue remodeling, and cell survival. J
Clin Invest. 107:1055–1061. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bennett KL, Jackson DG, Simon JC, et al:
CD44 isoforms containing exon v3 are responsible for the
presentation of heparin binding growth factor. J Cell Biol.
128:687–698. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xue J, Xu Y and Zhang Z: Lymphocyte
apoptosis in asthmatic patients and its molecular mechanism.
Zhonghua Jie He He Hu Xi Za Zhi. 22:555–557. 1999.(In Chinese).
|
|
13
|
Lamb JP, James A, Carroll N, et al:
Reduced apoptosis of memory T-cells in the inner airway wall of
mild and severe asthma. Eur Respir J. 26:265–270. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee JL, Wang MJ, Sudhir PR, et al:
Osteopontin promotes integrin activation through outside-in and
inside-out mechanisms: OPN-CD44V interaction enhances survival in
gastrointestinal cancer cells. 67:2089–2097. 2007.
|
|
15
|
Hegde VL, Singh NP, Prakash S, et al: CD44
mobilization in allogeneic dendritic cell-T cell immunological
synapse plays a key role in T cell activation. J Leukoc Biol.
84:134–142. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xavier R, Brennan T, Li Q, et al: Membrane
compartmentation is required for efficient T cell activation.
Immunity. 8:723–732. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Viola A, Schroeder S, Sakakibara Y, et al:
T lymphocyte costimulation mediated by reorganization of membrane
microdomains. Science. 283:680–682. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Neame SJ, Uff CR, Sheikh H, et al: CD44
exhibits a cell type dependent interaction with Triton X-100
insoluble, lipid rich, plasma membrane domains. J Cell Sci.
108:3127–3135. 1995.PubMed/NCBI
|
|
19
|
Ilangumaran S, Briol A and Hoessli DC:
CD44 selectively associates with active Src family protein tyrosine
kinases Lck and Fyn in glycosphingolipid-rich plasma membrane
domains of human peripheral blood lymphocytes. Blood. 91:3901–3908.
1998.
|
|
20
|
Foger N, Marhaba R and Zoller M:
Involvement of CD44 in cytoskeleton rearrangement and raft
reorganization in T cells. J Cell Sci. 114:1169–1178.
2001.PubMed/NCBI
|
|
21
|
Mojtabavi N, Dekan G, Stingl G and Epstein
MM: Long-lived Th2 memory in experimental allergic asthma. J
Immunol. 169:4788–4796. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Günthert U and Johansson B: CD44 – a
protein family involved in autoimmune diseases and apoptosis.
Immunologist. 8:106–109. 2001.
|
|
23
|
Mielgo A, van Driel M, Bloem A, et al: A
novel antiapoptotic mechanism based on interference of Fas
signaling by CD44 variant isoforms. Cell Death Differ. 13:465–477.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wittig BM, Johansson B, Zoller M, et al:
Abrogation of experimental colitis correlates with increased
apoptosis in mice deficient for CD44v7. J Exp Med. 191:2053–2063.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hoffmann U, Heilmann K, Hayford C, et al:
CD44v7 ligation downregulates the inflammatory immune response in
Crohn’s disease patients by apoptosis induction in mononuclear
cells from the lamina propria. Cell Death Differ. 14:1542–1551.
2007.PubMed/NCBI
|
